Duloxetine in comparison with methylphenidate in treatment of adolescents with ADHD

被引：0
|
作者：
Dodangi, Nasrin [1 ]
Tehrani-Doost, Mehdi [1 ]
Mahmoudi-gharaei, Javad [2 ]
Rajabi, Gilda [2 ]
机构：
[1] Univ Tehran Med Sci, Psychiat, Tehran, Iran
[2] Univ Tehran Med Sci, Tehran, Iran
来源：
EUROPEAN CHILD & ADOLESCENT PSYCHIATRY | 2011年 / 20卷 / 01期
关键词：
D O I：
暂无
中图分类号：
B844 [发展心理学（人类心理学）];
学科分类号：
040202 ;
摘要：
P01-06
引用
收藏
页码：S116 / S116
页数：1
相关论文
共 50 条
  • [31] PHARMACOGENOMICS OF METHYLPHENIDATE TREATMENT OF DANISH CHILDREN WITH ADHD
    Madsen, Majbritt Busk
    Kaalund-Brok, Kristine
    Jeppesen, Pia
    Pagsberg, Anne Katrine
    Houmann, Tine
    Plessen, Kerstin
    Thompson, Wesley
    Kadarmideen, Haja N.
    Rasmussen, Henrik
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S868 - S868
  • [32] Methylphenidate transdermal system (MTS) for the treatment of ADHD
    Dugue, G
    Pratt, RD
    DRUG AND ALCOHOL DEPENDENCE, 2006, 83 : S86 - S86
  • [33] Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
    Storebo, Ole Jakob
    Storm, Maja Rosenberg Overby
    Ribeiro, Johanne Pereira
    Skoog, Maria
    Groth, Camilla
    Callesen, Henriette E.
    Schaug, Julie Perrine
    Rasmussen, Pernille Darling
    Huus, Christel-Mie L.
    Zwi, Morris
    Kirubakaran, Richard
    Simonsen, Erik
    Gluud, Christian
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (03):
  • [34] Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
    Storebo, Ole Jakob
    Ramstad, Erica
    Krogh, Helle B.
    Nilausen, Trine Danvad
    Skoog, Maria
    Holmskov, Mathilde
    Rosendal, Susanne
    Groth, Camilla
    Magnusson, Frederik L.
    Moreira-Maia, Carlos R.
    Gillies, Donna
    Rasmussen, Kirsten Buch
    Gauci, Dorothy
    Zwi, Morris
    Kirubakaran, Richard
    Forsbol, Bente
    Simonsen, Erik
    Gluud, Christian
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (11):
  • [35] Reduced pain perception in children and adolescents with ADHD is normalized by methylphenidate
    Nicole Wolff
    Katya Rubia
    Hildtraud Knopf
    Heike Hölling
    Julia Martini
    Stefan Ehrlich
    Veit Roessner
    Child and Adolescent Psychiatry and Mental Health, 10
  • [36] Predicting the Response of Children and Adolescents With ADHD to Methylphenidate: A Systematic Review
    Pagnier, Maryse
    JOURNAL OF ATTENTION DISORDERS, 2023, 27 (12) : 1377 - 1392
  • [37] Steady-state pharmacokinetics of OROS® methylphenidate in adolescents with ADHD
    Auiler, JF
    Parasrampuria, DA
    Gelotte, CK
    Zinsenheim, JR
    Silber, SS
    Bowen, DL
    PEDIATRIC RESEARCH, 2004, 55 (04) : 589A - 589A
  • [38] WHO Essential Medicines List and methylphenidate for ADHD in children and adolescents
    Ponnou, Sebastien
    Timimi, Sami
    Briffault, Xavier
    Batstra, Laura
    Gotzsche, Peter C.
    Gonon, Francois
    LANCET PSYCHIATRY, 2024, 11 (02): : 92 - 93
  • [39] TREATMENT OF ADHD: DRUGS OR NOT DRUGS? PRESCRIBING OF METHYLPHENIDATE
    Wong, I. C. K.
    CHILD CARE HEALTH AND DEVELOPMENT, 2010, 36 : 31 - 32
  • [40] The CoMeCo-Trial: comparison of the efficacy of two methylphenidate preparations for children and adolescents with ADHD in a natural setting
    Doepfner, Manfred
    Ose, Claudia
    Fischer, Roland
    Ammer, Richard
    Scherag, Andre
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2011, 20 (01) : S116 - S116
12345